Abstract—Increasing evidence has suggested that locally produced angiotensin II (Ang II) plays an important role in the development of cardiac hypertrophy through the Ang II type 1 receptor (AT1).We ...

A study from Canada has raised concerns about certain blood pressure medications possibly being linked to a higher risk of ...

What do I need to do to get disability benefits from Social Security? I’m 60 years old and have a medical condition that ...

For high-risk patients with type 2 diabetes, oral semaglutide reduced risk for major cardiovascular and ischemic limb-related ...

Type II tumors generally are less well differentiated and have poorer prognoses than type I tumors, and they account for a disproportionate number of endometrial cancer deaths (40% of deaths, whereas ...

The newly approved product is a generic version of GIAPREZA, originally developed by La Jolla Pharma LLC, and is intended for use in critical care settings.

Richard Lafayette, MD, FACP, explains why a REMS program is not required for the endothelin A receptor antagonist and how ...

Researchers at the University of Tsukuba have developed a novel mouse model that allows them to induce dysfunction in only ...

Gland Pharma shares gained 3.2 per cent in trade on Tuesday, logging an intraday high at ₹1,800 per share on BSE. The stock ...

Earlier this month, the company's material subsidiary Cenexi also received a final inspection report from France's drug ...

Angiotensin II-receptor antagonists are well tolerated and are as effective as ACE inhibitors in decreasing blood pressure. Introduction. High blood pressure affects over 50 million Americans, but ...

Background—The mechanisms behind the beneficial effects of renin-angiotensin system blockade after myocardial infarction (MI) are not fully elucidated but may include interference with tissue ...